Krystal Biotech Inc (KRYS)

EBITDA Margin

56.74%

Quarterly · Period ending:

KRYS logo

KRYS EBITDA Margin

Latest reported56.74%
KRYS Quarterly EBITDA Margin (0.00% → 56.74%)
High-resolution chart · PNG

KRYS ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
56.7387%
54.2881%
36.9787%
50.6912%
50.3092%
51.2922%
55.0423%
43.4895%
32.8482%
16.4088%
28.8636%
959.7008%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-1,054.428%
-782.5043%
-418.5005%
-1,369.5853%
-1,415.6069%
-1,792.9134%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.